8-K

Company

Compass Therapeutics, Inc.

Filed

December 17, 2020

Period of Report

December 12, 2020

Accession Number

0001564590-20-057477

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →